Medial Amygdalar Tau Is Associated With Mood Symptoms in Preclinical Alzheimer's Disease
- PMID: 39059466
- PMCID: PMC11625605
- DOI: 10.1016/j.bpsc.2024.07.012
Medial Amygdalar Tau Is Associated With Mood Symptoms in Preclinical Alzheimer's Disease
Abstract
Background: While the amygdala receives early tau deposition in Alzheimer's disease (AD) and is involved in social and emotional processing, the relationship between amygdalar tau and early neuropsychiatric symptoms in AD is unknown. We sought to determine whether focal tau binding in the amygdala and abnormal amygdalar connectivity were detectable in a preclinical AD cohort and identify relationships between these and self-reported mood symptoms.
Methods: We examined 598 individuals (347 amyloid positive [58% female], 251 amyloid negative [62% female] subset in tau positron emission tomography and functional magnetic resonance imaging cohorts) from the A4 (Anti-Amyloid Treatment in Asymptomatic AD) Study. In the tau positron emission tomography cohort, we used amygdalar segmentations to examine representative nuclei from 3 functional divisions of the amygdala. We analyzed between-group differences in division-specific tau binding in the amygdala in preclinical AD. We conducted seed-based functional connectivity analyses from each division in the functional magnetic resonance imaging cohort. Finally, we conducted exploratory post hoc correlation analyses between neuroimaging biomarkers of interest and anxiety and depression scores.
Results: Amyloid-positive individuals demonstrated increased tau binding in the medial and lateral amygdala, and tau binding in these regions was associated with mood symptoms. Across amygdalar divisions, amyloid-positive individuals had relatively higher regional connectivity from the amygdala to other temporal regions, the insula, and the orbitofrontal cortex, but medial amygdala to retrosplenial cortex connectivity was lower. Medial amygdala to retrosplenial connectivity was negatively associated with anxiety symptoms, as was retrosplenial tau.
Conclusions: Our findings suggest that preclinical tau deposition in the amygdala and associated changes in functional connectivity may be related to early mood symptoms in AD.
Keywords: Amygdala; Anxiety; Default mode network; Depression; Functional networks; Preclinical Alzheimer’s disease.
Copyright © 2024 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
DISCLOSURES
WX is currently employed in a fellowship role at Unlearn.AI Inc. All other authors report no biomedical financial interests or potential conflicts of interest.
Update of
-
Medial amygdalar tau is associated with anxiety symptoms in preclinical Alzheimer's disease.bioRxiv [Preprint]. 2024 Jun 3:2024.06.03.597160. doi: 10.1101/2024.06.03.597160. bioRxiv. 2024. Update in: Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Dec;9(12):1301-1311. doi: 10.1016/j.bpsc.2024.07.012. PMID: 38895308 Free PMC article. Updated. Preprint.
References
-
- Benoit M, Dygai I, Migneco O, Robert PH, Bertogliati C, Darcourt J, et al. (1999): Behavioral and psychological symptoms in Alzheimer’s disease. Relation between apathy and regional cerebral perfusion. Dement Geriatr Cogn Disord 10: 511–7. - PubMed
-
- Kaufer DI, Cummings JL, Christine D, Bray T, Castellon S, Masterman D, et al. (1998): Assessing the impact of neuropsychiatric symptoms in Alzheimer’s disease: the Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc 46: 210–215. - PubMed
-
- Johansson L, Guo X, Duberstein PR, Hallstrom T, Waern M, Ostling S, Skoog I (2014): Midlife personality and risk of Alzheimer disease and distress: a 38-year follow-up. Neurology 83: 1538–44. - PubMed
-
- Johansson M, Stomrud E, Lindberg O, Westman E, Johansson PM, van Westen D, et al. (2020): Apathy and anxiety are early markers of Alzheimer’s disease. Neurobiology of Aging 85: 74–82. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
